Pfizer invests over $2.5 billion to expand manufacturing in Europe

Pfizer is investing more than $2.5 billion in its drug manufacturing plants in Belgium and Ireland as it prepares to launch new products that it hopes will be able to make up for lost profits as patents expire and the COVID-19 pandemic.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner